Australis Capital Inc.

CNSX:AUSA Stock Report

Market Cap: CA$8.7m

Australis Capital Valuation

Is AUSA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AUSA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate AUSA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate AUSA's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AUSA?

Key metric: As AUSA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AUSA. This is calculated by dividing AUSA's market cap by their current revenue.
What is AUSA's PS Ratio?
PS Ratio0.9x
SalesCA$9.47m
Market CapCA$8.75m

Price to Sales Ratio vs Peers

How does AUSA's PS Ratio compare to its peers?

The above table shows the PS ratio for AUSA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average12.4x
PWR Captiva Verde Wellness
30.7xn/aCA$7.2m
GLOW Glow Lifetech
13.1xn/aCA$7.3m
LOBE Lobe Sciences
5.3xn/aCA$3.4m
HERB Herbal Dispatch
0.5xn/aCA$4.9m
AUSA Australis Capital
0.9xn/aCA$8.7m

Price-To-Sales vs Peers: AUSA is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (2.8x).

Price to Sales Ratio vs Industry

How does AUSA's PS Ratio compare vs other companies in the CA Pharmaceuticals Industry?

28 CompaniesPrice / SalesEstimated GrowthMarket Cap
AYR.A Ayr Wellness
0.1x4.0%US$48.11m
IAN iAnthus Capital Holdings
0.1xn/aUS$23.14m
TIUM.U Cansortium
0.2xn/aUS$22.56m
CWEB Charlotte's Web Holdings
0.2x3.2%US$15.32m
AUSA 0.9xIndustry Avg. 0.8xNo. of Companies28PS012345+
28 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AUSA is good value based on its Price-To-Sales Ratio (0.9x) compared to the Canadian Pharmaceuticals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is AUSA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AUSA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate AUSA's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/01/16 02:28
End of Day Share Price 2022/10/19 00:00
Earnings2022/03/31
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Australis Capital Inc. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nathaniel CallowayEdison Investment Research